基因在工作中的作用:B型血友病治疗进入了一个新时代
Madison W Northington1, Sarah E Rice1, Abigail L Holmes1
1Department of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Auburn, AL, USA.
概括
基因疗法etranacogene dezaparvovec和fidanacogene elaparvovec为B型血友病提供了潜在的治愈治疗方法. 这些新疗法显著减少出血发作和因子缩需求,改善患者的生活质量.
科学领域:
- 血液学 血液学 血液学
- 基因治疗 基因治疗
- 药理学 药理学是指药理学的学科.
背景情况:
- 血友病B是一种罕见的,遗传性出血疾病,由凝血因子IX (FIX) 缺乏引起.
- 目前的治疗方法包括繁重的预防和按需使用凝血因子缩剂 (CFCs).
- 最近FDA批准了埃特拉纳科根德萨帕尔沃维克和费达纳科根埃拉帕尔沃维克,这标志着B型血友病管理的新时代.
研究的目的:
- 为了解决B型血友病的当前治疗策略提供了概述.
- 专注于新型基因疗法的疗效和安全性:埃特拉诺基因德萨帕尔沃维克和菲达诺基因埃拉帕尔沃维克.
主要方法:
- 对当前和新兴的血友病B治疗方法的文献综述.
- 对乙太诺基因desaparvovec和菲达诺基因elaparvovec的临床试验数据的分析.
- 专注于基于基因传递系统的腺相关病毒 (AAV) 载体.
主要成果:
- 这两种基因疗法都使用不同的AAV血清型来产生人类FIX的功能帕多瓦变体 (R338L).
- 临床试验表明FIX度增加,自发出血事件减少.
- 有效性被证明是一次终身的管理,减少了预防性CFCs的需要.
结论:
- 乙特拉诺基因desaparvovec和菲达诺基因elaparvovec代表了B型血友病的潜在治疗选择.
- 这些基因疗法通过减少治疗负担显著提高了患者的生活质量.
- 长期安全性和耐用性仍然是持续监测和研究的关键领域.
更多相关视频
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
602
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
602
01:24Disorders of Hemostasis
690
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
690
02:45Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K
01:05Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K
01:28Esophageal Varices-II: Clinical Features and Management
42
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
42